Selected research
Industry Research
EPA and DHA Formula Industry Research Report 2026
Market perspective
The global EPA and DHA Formula market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for EPA and DHA Formula is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for EPA and DHA Formula is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for EPA and DHA Formula is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of EPA and DHA Formula include Doctor's Nutrition, Efamol, Jarrow Formulas, Lepivits, Metagenics, Nature's Way Products, Now, Perelel and Puori, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global EPA and DHA Formula market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
EPA and DHA Formula Market by Company
Doctor's Nutrition
Efamol
Jarrow Formulas
Lepivits
Metagenics
Nature's Way Products
Now
Perelel
Puori
Ross J. Barr
Thorne
Youtheory
EPA and DHA Formula Segment by Type
From Plants
From Animals
EPA and DHA Formula Segment by Application
Online Sales
Offline Sales
EPA and DHA Formula Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EPA and DHA Formula market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of EPA and DHA Formula and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EPA and DHA Formula.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of EPA and DHA Formula manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of EPA and DHA Formula by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of EPA and DHA Formula in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- From Plants
- From Animals
Applications
- Online Sales
- Offline Sales
Companies covered
- Doctor's Nutrition
- Efamol
- Jarrow Formulas
- Lepivits
- Metagenics
- Nature's Way Products
- Now
- Perelel
- Puori
- Ross J. Barr
- Thorne
- Youtheory
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global EPA and DHA Formula Market Size (2021-2032)
- 2.2.2 Global EPA and DHA Formula Sales (2021-2032)
- 2.2.3 Global EPA and DHA Formula Market Average Price (2021-2032)
- 2.3 EPA and DHA Formula by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 From Plants
- 2.3.3 From Animals
- 2.4 EPA and DHA Formula by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Sales
- 2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global EPA and DHA Formula Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global EPA and DHA Formula Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global EPA and DHA Formula Revenue of Manufacturers (2021-2026)
- 3.4 Global EPA and DHA Formula Average Price by Manufacturers (2021-2026)
- 3.5 Global EPA and DHA Formula Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of EPA and DHA Formula, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of EPA and DHA Formula, Product Type & Application
- 3.8 Global Manufacturers of EPA and DHA Formula, Established Date
- 3.9 Global EPA and DHA Formula Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Doctor's Nutrition
- 4.1.1 Doctor's Nutrition Company Information
- 4.1.2 Doctor's Nutrition Business Overview
- 4.1.3 Doctor's Nutrition EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Doctor's Nutrition EPA and DHA Formula Product Portfolio
- 4.1.5 Doctor's Nutrition Recent Developments
- 4.2 Efamol
- 4.2.1 Efamol Company Information
- 4.2.2 Efamol Business Overview
- 4.2.3 Efamol EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Efamol EPA and DHA Formula Product Portfolio
- 4.2.5 Efamol Recent Developments
- 4.3 Jarrow Formulas
- 4.3.1 Jarrow Formulas Company Information
- 4.3.2 Jarrow Formulas Business Overview
- 4.3.3 Jarrow Formulas EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jarrow Formulas EPA and DHA Formula Product Portfolio
- 4.3.5 Jarrow Formulas Recent Developments
- 4.4 Lepivits
- 4.4.1 Lepivits Company Information
- 4.4.2 Lepivits Business Overview
- 4.4.3 Lepivits EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Lepivits EPA and DHA Formula Product Portfolio
- 4.4.5 Lepivits Recent Developments
- 4.5 Metagenics
- 4.5.1 Metagenics Company Information
- 4.5.2 Metagenics Business Overview
- 4.5.3 Metagenics EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Metagenics EPA and DHA Formula Product Portfolio
- 4.5.5 Metagenics Recent Developments
- 4.6 Nature's Way Products
- 4.6.1 Nature's Way Products Company Information
- 4.6.2 Nature's Way Products Business Overview
- 4.6.3 Nature's Way Products EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Nature's Way Products EPA and DHA Formula Product Portfolio
- 4.6.5 Nature's Way Products Recent Developments
- 4.7 Now
- 4.7.1 Now Company Information
- 4.7.2 Now Business Overview
- 4.7.3 Now EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Now EPA and DHA Formula Product Portfolio
- 4.7.5 Now Recent Developments
- 4.8 Perelel
- 4.8.1 Perelel Company Information
- 4.8.2 Perelel Business Overview
- 4.8.3 Perelel EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Perelel EPA and DHA Formula Product Portfolio
- 4.8.5 Perelel Recent Developments
- 4.9 Puori
- 4.9.1 Puori Company Information
- 4.9.2 Puori Business Overview
- 4.9.3 Puori EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Puori EPA and DHA Formula Product Portfolio
- 4.9.5 Puori Recent Developments
- 4.10 Ross J. Barr
- 4.10.1 Ross J. Barr Company Information
- 4.10.2 Ross J. Barr Business Overview
- 4.10.3 Ross J. Barr EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Ross J. Barr EPA and DHA Formula Product Portfolio
- 4.10.5 Ross J. Barr Recent Developments
- 4.11 Thorne
- 4.11.1 Thorne Company Information
- 4.11.2 Thorne Business Overview
- 4.11.3 Thorne EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Thorne EPA and DHA Formula Product Portfolio
- 4.11.5 Thorne Recent Developments
- 4.12 Youtheory
- 4.12.1 Youtheory Company Information
- 4.12.2 Youtheory Business Overview
- 4.12.3 Youtheory EPA and DHA Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Youtheory EPA and DHA Formula Product Portfolio
- 4.12.5 Youtheory Recent Developments
5 Global EPA and DHA Formula Market Scenario by Region
- 5.1 Global EPA and DHA Formula Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global EPA and DHA Formula Sales by Region: 2021-2032
- 5.2.1 Global EPA and DHA Formula Sales by Region: 2021-2026
- 5.2.2 Global EPA and DHA Formula Sales by Region: 2027-2032
- 5.3 Global EPA and DHA Formula Revenue by Region: 2021-2032
- 5.3.1 Global EPA and DHA Formula Revenue by Region: 2021-2026
- 5.3.2 Global EPA and DHA Formula Revenue by Region: 2027-2032
- 5.4 North America EPA and DHA Formula Market Facts & Figures by Country
- 5.4.1 North America EPA and DHA Formula Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America EPA and DHA Formula Sales by Country (2021-2032)
- 5.4.3 North America EPA and DHA Formula Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe EPA and DHA Formula Market Facts & Figures by Country
- 5.5.1 Europe EPA and DHA Formula Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe EPA and DHA Formula Sales by Country (2021-2032)
- 5.5.3 Europe EPA and DHA Formula Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific EPA and DHA Formula Market Facts & Figures by Country
- 5.6.1 Asia Pacific EPA and DHA Formula Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific EPA and DHA Formula Sales by Country (2021-2032)
- 5.6.3 Asia Pacific EPA and DHA Formula Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America EPA and DHA Formula Market Facts & Figures by Country
- 5.7.1 South America EPA and DHA Formula Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America EPA and DHA Formula Sales by Country (2021-2032)
- 5.7.3 South America EPA and DHA Formula Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa EPA and DHA Formula Market Facts & Figures by Country
- 5.8.1 Middle East and Africa EPA and DHA Formula Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa EPA and DHA Formula Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa EPA and DHA Formula Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global EPA and DHA Formula Sales by Type (2021-2032)
- 6.1.1 Global EPA and DHA Formula Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global EPA and DHA Formula Sales Market Share by Type (2021-2032)
- 6.2 Global EPA and DHA Formula Revenue by Type (2021-2032)
- 6.2.1 Global EPA and DHA Formula Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global EPA and DHA Formula Revenue Market Share by Type (2021-2032)
- 6.3 Global EPA and DHA Formula Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global EPA and DHA Formula Sales by Application (2021-2032)
- 7.1.1 Global EPA and DHA Formula Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global EPA and DHA Formula Sales Market Share by Application (2021-2032)
- 7.2 Global EPA and DHA Formula Revenue by Application (2021-2032)
- 7.2.1 Global EPA and DHA Formula Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global EPA and DHA Formula Revenue Market Share by Application (2021-2032)
- 7.3 Global EPA and DHA Formula Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 EPA and DHA Formula Value Chain Analysis
- 8.1.1 EPA and DHA Formula Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 EPA and DHA Formula Production Mode & Process
- 8.2 EPA and DHA Formula Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 EPA and DHA Formula Distributors
- 8.2.3 EPA and DHA Formula Customers
9 Global EPA and DHA Formula Analyzing Market Dynamics
- 9.1 EPA and DHA Formula Industry Trends
- 9.2 EPA and DHA Formula Industry Drivers
- 9.3 EPA and DHA Formula Industry Opportunities and Challenges
- 9.4 EPA and DHA Formula Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst